Agglutination Assays
Agglutination assays detect specific antigens or antibodies by observing whether clumping occurs when antibodies bind to matching antigens. These tests are widely used in blood typing, disease diagnosis, and bacterial identification because the results are visible to the naked eye, making them fast and practical in clinical labs.
Direct vs. Indirect Agglutination
The key distinction here is whether the antigen being detected is already sitting on a cell surface or floating free in solution.
Direct agglutination uses antibodies that bind directly to antigens naturally present on cells or particles (bacteria, red blood cells). The antibodies cross-link multiple cells, forming visible clumps.
- Blood typing is the classic example: you mix a patient's red blood cells with anti-A, anti-B, or anti-D antibodies and watch for clumping.
- Bacterial identification works similarly. For instance, Streptococcus species can be grouped (Lancefield grouping) based on specific cell wall antigens that agglutinate with the corresponding antibody.
Indirect (passive) agglutination detects soluble antigens or antibodies that wouldn't clump on their own. To make agglutination visible, you attach the antigen (or antibody) to a carrier particle like latex beads or red blood cells. If the target is present in the sample, it cross-links the coated particles and produces clumping.
- The Widal test diagnoses typhoid fever by detecting patient antibodies against Salmonella typhi antigens attached to particles.
- The rheumatoid factor test detects autoantibodies (rheumatoid factor) in a patient's serum. These autoantibodies bind to IgG-coated latex particles, causing agglutination.
Determining antibody titer: You can quantify how much antibody is in a sample by performing serial twofold dilutions (1:2, 1:4, 1:8, etc.) and finding the highest dilution that still produces visible agglutination. That dilution is the titer, and a higher titer means more antibody is present.
Applications of Hemagglutination
Hemagglutination refers specifically to the agglutination of red blood cells (RBCs). It can be caused by antibodies, but also by viruses and bacteria.
Viral hemagglutination occurs when certain viruses (notably influenza) have surface proteins (hemagglutinin) that bind directly to receptors on RBCs, causing them to clump. This property is exploited in the hemagglutination inhibition (HI) test:
- Mix the patient's serum with a known virus.
- Add RBCs to the mixture.
- If the patient has antibodies against the virus, those antibodies bind the virus and block it from agglutinating the RBCs. The RBCs settle to the bottom instead of clumping.
- Inhibition of hemagglutination = positive result (antibodies are present).
Bacterial hemagglutination occurs when bacteria like Mycoplasma pneumoniae produce adhesins that bind RBC surface receptors. The indirect hemagglutination test detects patient antibodies against such bacteria by coating RBCs with bacterial antigens and checking whether the patient's serum causes agglutination.
Blood Typing and Transfusion
Blood Typing Through Agglutination
ABO typing determines blood type based on which antigens are on the patient's RBCs and which antibodies are in their serum.
| Blood Type | Antigens on RBCs | Antibodies in Serum | Agglutinates with |
|---|---|---|---|
| A | A | Anti-B | Anti-A antibodies |
| B | B | Anti-A | Anti-B antibodies |
| AB | A and B | Neither | Anti-A or Anti-B |
| O | Neither | Anti-A and Anti-B | Neither |
| The test is straightforward: place drops of the patient's blood on a slide, add anti-A to one drop and anti-B to another, and observe which (if any) agglutinate. |
Rh typing checks for the D antigen on RBCs. Mix the patient's RBCs with anti-D antibodies. Agglutination means Rh-positive; no agglutination means Rh-negative. Rh status matters most in pregnancy (Rh-negative mothers carrying Rh-positive fetuses can develop anti-D antibodies) and transfusion.
Cross-Matching for Blood Transfusions
Cross-matching goes beyond ABO/Rh typing to confirm that a specific donor's blood is compatible with a specific recipient. Here are the steps:
- Type both donor and recipient blood for ABO and Rh.
- Screen the recipient's serum for unexpected antibodies (antibody screen) that might react with less common blood group antigens.
- Cross-match by mixing the recipient's serum with the donor's RBCs.
- Agglutination = incompatible. Do not transfuse.
- No agglutination = compatible. Safe to transfuse.
Transfusing incompatible blood triggers the recipient's antibodies to attack donor RBCs, causing hemolytic transfusion reactions. These can lead to massive RBC destruction, acute kidney injury, and potentially death.
Cross-reactivity is worth knowing about: antibodies sometimes recognize similar epitopes on different antigens, which can produce false-positive agglutination results during cross-matching.
Additional Considerations in Agglutination Assays
Prozone effect: When antibody concentration in a sample is very high, there are so many antibodies that each antigen gets coated by a single antibody rather than being cross-linked between two. This prevents the lattice formation needed for visible clumping, producing a false-negative result. The fix is to dilute the sample and retest.
Cold agglutinins: These are antibodies (typically IgM) that cause RBC agglutination at temperatures below 37°C. They can interfere with blood typing and cross-matching if tests are performed at room temperature. Cold agglutinins are clinically associated with infections like Mycoplasma pneumoniae and certain lymphomas.
Complement fixation: This is a separate but related technique where complement proteins are consumed ("fixed") during an antigen-antibody reaction. If complement is used up, it won't be available to lyse indicator RBCs in a second step, signaling a positive result. It's particularly useful for detecting antibodies against certain viral and bacterial pathogens, though it has largely been replaced by newer methods in many labs.